Created at Source Raw Value Validated value
June 27, 2024, 4 p.m. usa

inclusion criteria: 1. age ≥18 years. 2. hospitalization. 3. sars-cov-2 viral nucleic acid positive within 3 days. 4. lab test result pending plus a high clinical suspicion for sars-cov-2 (fever and cough for ≤ 7 days, bilateral pulmonary infiltrates on imaging or new hypoxemia with spo2 ≤94% on room air or no alternative explanation for respiratory symptoms). 5. willing and able to provide consent or by authorized proxy.

inclusion criteria: 1. age ≥18 years. 2. hospitalization. 3. sars-cov-2 viral nucleic acid positive within 3 days. 4. lab test result pending plus a high clinical suspicion for sars-cov-2 (fever and cough for ≤ 7 days, bilateral pulmonary infiltrates on imaging or new hypoxemia with spo2 ≤94% on room air or no alternative explanation for respiratory symptoms). 5. willing and able to provide consent or by authorized proxy.

Nov. 16, 2021, 6:30 p.m. usa

inclusion criteria: age ≥18 years. hospitalization. sars-cov-2 viral nucleic acid positive within 3 days. lab test result pending plus a high clinical suspicion for sars-cov-2 (fever and cough for ≤ 7 days, bilateral pulmonary infiltrates on imaging or new hypoxemia with spo2 ≤94% on room air or no alternative explanation for respiratory symptoms). willing and able to provide consent or by authorized proxy.

inclusion criteria: age ≥18 years. hospitalization. sars-cov-2 viral nucleic acid positive within 3 days. lab test result pending plus a high clinical suspicion for sars-cov-2 (fever and cough for ≤ 7 days, bilateral pulmonary infiltrates on imaging or new hypoxemia with spo2 ≤94% on room air or no alternative explanation for respiratory symptoms). willing and able to provide consent or by authorized proxy.

Oct. 26, 2020, 11:31 p.m. usa

inclusion criteria: 1. age ≥18 years. 2. hospitalization. 3. sars-cov-2 viral nucleic acid positive within 3 days. 4. lab test result pending plus a high clinical suspicion for sars-cov-2 (fever and cough for ≤ 7 days, bilateral pulmonary infiltrates on imaging or new hypoxemia with spo2 ≤94% on room air or no alternative explanation for respiratory symptoms). 5. willing and able to provide consent or by authorized proxy.

inclusion criteria: 1. age ≥18 years. 2. hospitalization. 3. sars-cov-2 viral nucleic acid positive within 3 days. 4. lab test result pending plus a high clinical suspicion for sars-cov-2 (fever and cough for ≤ 7 days, bilateral pulmonary infiltrates on imaging or new hypoxemia with spo2 ≤94% on room air or no alternative explanation for respiratory symptoms). 5. willing and able to provide consent or by authorized proxy.